Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization

1. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

   Shunshun Bao, Mohammad Darvishi, Ali H. Amin +12

   Шарҳ мақолаChemokine receptors and signalingJournal of Cancer Research and Clinical Oncology20231 иқтибос

   ABIABI:AkademIndex/openalex/2023.review-article.000025

2. Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy

   Alireza Bayani, Munthar Kadhim Abosaoda, Jasur Rizaev +3

   Шарҳ мақолаAdvanced biosensing and bioanalysis techniquesClinical and Experimental Medicine20251 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000015